Literature DB >> 11944083

Importance of a small N-terminal region in mammalian peptide transporters for substrate affinity and function.

F Döring1, C Martini, J Walter, H Daniel.   

Abstract

The two closely related, proton-coupled, electrogenic mammalian peptide transporters PEPT1 and PEPT2 differ substantially in substrate affinity and mode of function. The intestinal carrier PEPT1 has a lower affinity for most substrates than the isoform PEPT2 that is expressed in kidney, lung, brain and other tissues. A previous analysis of PEPT1-PEPT2 chimeras has suggested that the N-terminal half of the carrier proteins is important for substrate affinity. We constructed and analyzed new PEPT1-PEPT2 chimeras for identifying smaller segments within the N-terminal region of the transporter proteins that contribute to the kinetic properties. The first 59 or 91 amino-acid residues of PEPT1 were used to replace the corresponding region in PEPT2 leading to the chimeras CH3 and CH4, which could be analyzed when expressed in Xenopus laevis oocytes. Substrate affinities of both chimeras for the zwitterionic substrate D-Phe-Ala ranged between those that are characteristic for either PEPT1 or PEPT2, but when charged dipeptide substrates were employed, both chimeras possessed PEPT1-like affinities. The chimera CH3 carrying the N-terminal 59 amino-acid residues of PEPT1 exhibited a PEPT2-like phenotype with respect to pHout-dependency as well as to the current-voltage relationship of inward currents. In the chimera CH4 possessing the 91 amino-terminal residues of PEPT1, a pronounced alteration in the pHout-dependence was observed, with highest transport rates occurring at pH values as low as pH 4.0. Based on this analysis, we propose that the two identified aminoterminal regions in mammalian peptide carriers play an important role in determining the substrate affinity and also other characteristic features of the two transporter subtypes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11944083     DOI: 10.1007/s00232-001-0135-9

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  7 in total

Review 1.  Bioavailability through PepT1: the role of computer modelling in intelligent drug design.

Authors:  David W Foley; Jeyaganesh Rajamanickam; Patrick D Bailey; David Meredith
Journal:  Curr Comput Aided Drug Des       Date:  2010-03       Impact factor: 1.606

Review 2.  Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications.

Authors:  David E Smith; Benjamin Clémençon; Matthias A Hediger
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

3.  Protein cold adaptation strategy via a unique seven-amino acid domain in the icefish (Chionodraco hamatus) PEPT1 transporter.

Authors:  Antonia Rizzello; Alessandro Romano; Gabor Kottra; Raffaele Acierno; Carlo Storelli; Tiziano Verri; Hannelore Daniel; Michele Maffia
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

4.  Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2.

Authors:  Simon Newstead; David Drew; Alexander D Cameron; Vincent L G Postis; Xiaobing Xia; Philip W Fowler; Jean C Ingram; Elisabeth P Carpenter; Mark S P Sansom; Michael J McPherson; Stephen A Baldwin; So Iwata
Journal:  EMBO J       Date:  2010-12-03       Impact factor: 11.598

5.  Alternating access mechanism in the POT family of oligopeptide transporters.

Authors:  Nicolae Solcan; Jane Kwok; Philip W Fowler; Alexander D Cameron; David Drew; So Iwata; Simon Newstead
Journal:  EMBO J       Date:  2012-06-01       Impact factor: 11.598

6.  A charge pair interaction between Arg282 in transmembrane segment 7 and Asp341 in transmembrane segment 8 of hPepT1.

Authors:  Ashutosh A Kulkarni; Daryl L Davies; Jennifer S Links; Leena N Patel; Vincent H L Lee; Ian S Haworth
Journal:  Pharm Res       Date:  2006-09-29       Impact factor: 4.580

7.  Peptide transporter isoforms are discriminated by the fluorophore-conjugated dipeptides β-Ala- and d-Ala-Lys-N-7-amino-4-methylcoumarin-3-acetic acid.

Authors:  Gabor Kottra; Britta Spanier; Tiziano Verri; Hannelore Daniel
Journal:  Physiol Rep       Date:  2013-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.